Basic Information
ID: ALA4039464
Type: Functional
Description: Potentiation of CPA-induced antitumor activity against human U2932 cells xenografted in SCID mouse assessed as tumor growth inhibition at 7.5 mg/kg, ip for 5 days cotreated with 10 mg/kg NSC-59276 measured on day 12 post first treatment (Rvb = 67%)
Organism: Homo sapiens
Cell type: U2932
Activity Charts
Bioactivity
Activity Types for Assay ALA4039464
TGI
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 406.36 | 4.43 | 4.43 |